Sponsor: Ipsen
Protocol D-US-60010-001: An Open-label, randomised, multicentre, phase III study of Irinotecan liposome injection, Oxaliplatin, 5-fluorouracil/Leucovorin versus Nab-paclitaxel plus Gemcitabine in subjects who have not previously received chemotherapy for metastatic Adenocarcinoma of the Pancreas.
For more information please contact the clinical research department: 631-675-5075